Stay updated on ACTIV-5 / BET-B COVID-19 Clinical Trial
Sign up to get notified when there's something new on the ACTIV-5 / BET-B COVID-19 Clinical Trial page.

Latest updates to the ACTIV-5 / BET-B COVID-19 Clinical Trial page
- CheckyesterdayChange DetectedLocations section added with a comprehensive list of study sites across multiple US states and international locations (including Gyeonggi-do and Jongno-gu). The prior revision removed the HHS Vulnerability Disclosure and the location listings.SummaryDifference2%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedPublications are now described as automatically filled from PubMed and may not be about the study. The revision label has been updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check36 days agoChange DetectedRemoved the general government funding notice that warned information may not be up to date and that some site operations could be affected, which previously directed users to cc.nih.gov and opm.gov for status updates; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check58 days agoChange DetectedThe Locations section was updated to add new study sites and adjust existing ones for the BET-B trial.SummaryDifference0.2%

- Check80 days agoChange DetectedUpgrade to v3.2.0 includes a prominent government funding and operating status notice; previous v3.1.0 has been removed. If no further changes to core content are present, expect updated operating status information to be authoritative.SummaryDifference1%

- Check87 days agoChange DetectedUpdated page to v3.1.0; removed several drug-safety topic categories (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and retained the older version tag v3.0.2, suggesting a reorganization of content around a new version.SummaryDifference0.2%

Stay in the know with updates to ACTIV-5 / BET-B COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ACTIV-5 / BET-B COVID-19 Clinical Trial page.